Neurogenesis: Silencing the alternative
The transcription factor ztf-11 promotes neuronal differentiation by repressing other cell fates in the nematode worm C. elegans.
- Perelman School of Medicine, United States
During development, cells have to divide and differentiate to generate the various types of cells found in the adult organism. To do this, cells must activate the genes necessary to become the right type of cell, but also repress the genes that would drive them to different fates. Many of the transcription factors that activate gene expression during differentiation have been studied extensively, but only a few examples of transcription factors that repress unwanted cell fates have been described (Bellefroid et al., 1996; Vasconcelos and Castro, 2017).
Transcription factors are also important for cell fate reprogramming, a process through which an adult cell can lose its identity and become a new cell type. In vitro, this is usually done by forcing the expression of specific transcription factors.
The Myt1 family of transcription factors are specifically expressed in vertebrate neurons and are thought to repress non-neural fates. Myt1 proteins promote the formation of neurons (neurogenesis) in vertebrate embryos by blocking Notch signaling (Bellefroid et al., 1996; Vasconcelos et al., 2016). Forcing expression of Myt1l in cultured connective tissue cells called fibroblasts blocks the Notch pathway and represses non-neuronal genes, reprogramming these cells into neurons (Vierbuchen et al., 2010; Mall et al., 2017). It is not known whether Myt1 proteins repress a broad range of genes during in vivo development, partly because interpreting Myt1 loss of function in mammalian embryos is complicated by other related proteins that may have similar effects.
Now, in eLife, Kang Shen of Stanford University and co-workers – including Joo Lee as first author – report that ztf-11, the only member of the Myt1 family found in the nematode worm Caenorhabditis elegans, promotes neuronal differentiation by blocking other fates (Lee et al., 2019). All C. elegans individuals contain the same number of neuronal progenitors and neurons, providing a powerful framework to understand the process of neurogenesis (Sulston et al., 1983). Moreover, neurons formed during embryonic development in C. elegans are produced by undifferentiated progenitor cells (cells that can give rise to any cell type), whereas those formed in the larval stages are produced by skin cell precursors (Sulston and Horvitz, 1977). Lee et al. show that, like Myt1 proteins in mammals, ztf-11 is broadly expressed in both embryonic and larval neuronal progenitors.
First, Lee et al. investigate a natural reprogramming event during which a differentiated epithelial cell is transformed into a motor neuron (Jarriault et al., 2008). It is shown that ztf-11 is required to turn off epithelial gene expression in this reprogramming event. Next, it is shown that ztf-11 is also necessary to turn off epithelial gene expression during other neuronal differentiations in the larva, including the production of sensory neurons and glia from another epidermal cell.
Lee et al. also find that forcing expression of ztf-11 in epidermal cells that do not normally produce neurons was sufficient for these cells to lose epithelial identity and start to look and behave like neurons. This finding suggests that in absence of other epidermal-promoting factors, these epidermal cells would become neural cells. This is reminiscent of the hypothesis that the precursors of brain and skin cells in vertebrates have a neural ground state, which is inhibited by signaling molecules in epidermal cells (Hemmati-Brivanlou and Melton, 1997). Future work will reveal if a similar reprogramming by Myt1 proteins occurs in other systems.
Lee et al. then investigate the role of ztf-11 in Notch signaling. In vertebrates Myt1 appears to act by repressing the Notch target gene Hes1 (Vasconcelos and Castro, 2017). In the worm, however, ztf-11 is not required to repress the gene lin-22, which is the homolog of Hes1 in C. elegans. Rather, the regulation seems to go in the opposite direction, with lin-22 repressing a gene called lin-32/Atonal, which is an activator of ztf-11.
Together, these results show the parallels between ztf-11 and Myt1l-dependent repression of non-neuronal genes during fibroblast to neuron reprogramming (Mall et al., 2017), suggesting that similar pathways operate during in vitro and in vivo reprogramming.
Genome-wide expression changes in ztf-11 mutant embryos were measured with RNA-seq and suggest that ztf-11 is required in the embryo to fully repress both epithelial and muscle-specific genes, although it is unclear in which cells this regulation occurs. Worms mutant for ztf-11 have a lethal paralysis phenotype, and consistent with this Lee et al. find that progenitors of neurons in the embryo express ztf-11. Surprisingly, they also find that in the absence of ztf-11 a roughly normal number of neurons are generated.
A ztf-11 reporter was used to show that the gene is broadly expressed in early embryonic precursors that are fated to produce multiple cell types, and then lost from cells that do not produce any neurons. This differs from the situation in larvae, where ztf-11 is not expressed in progenitors but becomes activated specifically in cells that later become neurons. This suggests that the expression of ztf-11 in the embryo might prevent epithelial and muscle genes from being expressed too early (Figure 1A). In contrast to vertebrate Myt1, ztf-11 expression appears to be lost from most embryonic and larval neurons once they differentiate. This suggests that, at least in C. elegans, the role of ztf-11 may be to establish initial repression of inappropriate lineage genes, and that this repression is then maintained by other mechanisms (Figure 1B).
Figure 1
Expression of ztf-11 during neuronal development in C.elegans embryos and larvae.
(A) In C. elegans embryos, ztf-11 is expressed broadly in early progenitors (ztf-11+). These early progenitors subsequently differentiate to produce neuronal progenitors (in which expression of ztf-11 is maintained, thus repressing epithelial and muscle fates) and epithelial/muscle cells (which do not express ztf-11). The neuronal progenitors can differentiate to produce neurons or other cell types such as epithelial or muscle cells. Once neurons fully differentiate (pale blue at the bottom of the figure), they no longer express ztf-11. The mechanisms responsible for the repression of epithelial and muscle fates in these cells are not understood. (B) In C. elegans larvae, ztf-11 is not initially present in neuro-epithelial precursors or epithelial cells that eventually transdifferentiate into neurons. ztf-11 is turned on by pro-neural factors in differentiating neurons, where it represses epithelial fates. Differentiated neurons lack ztf-11 suggesting that other unknown factors take on the role of repression (bottom image).
Image credit: P Sivaramakrishnan and J I Murray
Further studies will be needed to identify these mechanisms, and to determine if similar broad transcriptional repressors exist for other cell types. This study is a significant step forward in our understanding of the repression mechanisms that restrict some but permit other fates to be established during embryogenesis.
References
-
Vertebrate neural inductionAnnual Review of Neuroscience 20:43–60.https://doi.org/10.1146/annurev.neuro.20.1.43
-
The embryonic cell lineage of the nematode Caenorhabditis elegansDevelopmental Biology 100:64–119.https://doi.org/10.1016/0012-1606(83)90201-4
-
Post-embryonic cell lineages of the nematode, Caenorhabditis elegansDevelopmental Biology 56:110–156.https://doi.org/10.1016/0012-1606(77)90158-0
Article and author information
Author details
Priya Sivaramakrishnan
Publication history
Copyright
© 2019, Sivaramakrishnan and Murray
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 951
- views
-
- 63
- downloads
-
- 0
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Neurogenesis: Silencing the alternative
eLife 8:e49635.
https://doi.org/10.7554/eLife.49635
Further reading
-
- Developmental Biology
- Genetics and Genomics
Paternal obesity has been implicated in adult-onset metabolic disease in offspring. However, the molecular mechanisms driving these paternal effects and the developmental processes involved remain poorly understood. One underexplored possibility is the role of paternally-induced effects on placenta development and function. To address this, we investigated paternal high-fat diet-induced obesity in relation to sperm histone H3 lysine 4 tri-methylation signatures, the placenta transcriptome and cellular composition. C57BL6/J male mice were fed either a control or high-fat diet for 10 weeks beginning at 6 weeks of age. Males were timed-mated with control-fed C57BL6/J females to generate pregnancies, followed by collection of sperm, and placentas at embryonic day (E)14.5. Chromatin immunoprecipitation targeting histone H3 lysine 4 tri-methylation (H3K4me3) followed by sequencing (ChIP-seq) was performed on sperm to define obesity-associated changes in enrichment. Paternal obesity corresponded with altered sperm H3K4me3 at promoters of genes involved in metabolism and development. Notably, sperm altered H3K4me3 was also localized at placental enhancers. Bulk RNA-sequencing on placentas revealed paternal obesity-associated sex-specific changes in expression of genes involved in hypoxic processes such as angiogenesis, nutrient transport, and imprinted genes, with a subset of deregulated genes showing changes in H3K4me3 in sperm at corresponding promoters. Paternal obesity was also linked to impaired placenta development; specifically, a deconvolution analysis revealed altered trophoblast cell lineage specification. These findings implicate paternal obesity-effects on placenta development and function as one potential developmental route to offspring metabolic disease.
-
- Developmental Biology
- Stem Cells and Regenerative Medicine
Deficient Anterior pituitary with common Variable Immune Deficiency (DAVID) syndrome results from NFKB2 heterozygous mutations, causing adrenocorticotropic hormone deficiency (ACTHD) and primary hypogammaglobulinemia. While NFKB signaling plays a crucial role in the immune system, its connection to endocrine symptoms is unclear. We established a human disease model to investigate the role of NFKB2 in pituitary development by creating pituitary organoids from CRISPR/Cas9-edited human induced pluripotent stem cells (hiPSCs). Introducing homozygous TBX19K146R/K146R missense pathogenic variant in hiPSC, an allele found in congenital isolated ACTHD, led to a strong reduction of corticotrophs number in pituitary organoids. Then, we characterized the development of organoids harboring NFKB2D865G/D865G mutations found in DAVID patients. NFKB2D865G/D865G mutation acted at different levels of development with mutant organoids displaying changes in the expression of genes involved on pituitary progenitor generation (HESX1, PITX1, LHX3), hypothalamic secreted factors (BMP4, FGF8, FGF10), epithelial-to-mesenchymal transition, lineage precursors development (TBX19, POU1F1) and corticotrophs terminal differentiation (PCSK1, POMC), and showed drastic reduction in the number of corticotrophs. Our results provide strong evidence for the direct role of NFKB2 mutations in the endocrine phenotype observed in patients leading to a new classification of a NFKB2 variant of previously unknown clinical significance as pathogenic in pituitary development.
